Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Savitz Ryan −$11.2M EVP, CFO & CBO sold 100% of stake
  2. Randhawa Simrat −$2.5M EVP, Head of R&D sold 85% of stake
  3. CARR EDWARD −$2.0M CHIEF ACCOUNTING OFFICER sold 100% of stake
  4. Read Simon −$327K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2021-06-01 Albers Jeffrey W. Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2021-04-19 Nichols David Wayne Chief Technical Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2021-04-19 Nichols David Wayne Chief Technical Officer Grant or award · Stock Option (Right to Buy) +175,000 175,000
2021-02-11 Atlas Venture Fund X, L.P. 10% owner Other disposition −968,726 3,148,399
2021-02-11 Olson Lisa See Remarks Grant or award · Stock Option (Right to Buy) +12,500 12,500
2021-02-11 DAVIS JOHN C. JR See Remarks Grant or award · Stock Option (Right to Buy) +72,500 72,500
2021-02-11 ZDRAVESKI ZORAN See Remarks Grant or award · Stock Option (Right to Buy) +67,700 67,700
2021-02-11 GARDNER JASON See Remarks Grant or award · Stock Option (Right to Buy) +112,500 112,500
2021-02-11 Stants Kristen Chief People Officer Grant or award · Stock Option (Right to Buy) +67,500 67,500
2020-12-22 Lawton Alison Frances Director Grant or award · Stock Option (Right to Buy) +36,377 36,377
2020-11-02 Mahoney Stephen F. See Remarks Grant or award · Stock Option (Right to Buy) +435,000 435,000
2020-09-14 Olson Lisa See Remarks Grant or award · Stock Option (Right to Buy) +120,000 120,000
2020-06-29 Booth Bruce Director Purchase +1,250,000 $8.00 $10.0M 1,250,000
2020-06-05 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 BYERS BLAKE Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 RONNEBERG AMY L Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 BONNEY MICHAEL W Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 Booth Bruce Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 McGeorge Anne Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +18,188 18,188

Page 17 of 24 · 470 trades